Back to results
US 8,575,192 B2Granted
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
AssigneeTheravance, Inc.
InventorsDaniel Marquess, Paul R. Fatheree, S. Derek Turner, Daniel D. Long
Life of this patent
Estimating the term…
Abstract
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Claims18
A tablet comprising a pharmaceutically acceptable carrier and a compound of the formula
- or a pharmaceutically-acceptable salt thereof.
A tablet comprising a pharmaceutically acceptable carrier and a hydrochloride salt of a compound of the formula
Dependencies are inferred from the claim text.